(firstQuint)Safety Study of Once-a-Day Dosing of Udenafil to Treat Erectile Dysfunction.

 Completer from parent study(DA8159_EDD_III)continued into a 24weeks open-label extension during which they received udenafil once daily.

 The study concluded with a 4-week ED treatment-free period.

.

 Safety Study of Once-a-Day Dosing of Udenafil to Treat Erectile Dysfunction@highlight

Phase : Phase III Indication : Erectile Dysfunction Study Design : open-label, fixed dose, 6-month extension study (parent study : DA8159_EDD_III)